title: Response to comment on "is addition of vasodilators to loop diuretics of value in the care of hospitalized acute heart failure patients? Real-world evidence from a retrospective analysis of a large United States hospital database".
authors: Temple University School of Medicine (Clinical Campus), Pittsburgh, Pennsylvania, United States. Electronic address: gradmana@temple.edu.
authors: Alan H
authors: AH
authors: Gradman
authors: Analysis Group, Montreal, Quebec, Canada.
authors: Francis
authors: F
authors: Vekeman
authors: Analysis Group, Boston, Massachusetts, United States.
authors: Adi
authors: A
authors: Eldar-Lissai
authors: Analysis Group, Boston, Massachusetts, United States.
authors: Alex
authors: A
authors: Trahey
authors: Analysis Group, Boston, Massachusetts, United States.
authors: Mei Sheng
authors: MS
authors: Duh
authors: Novartis Pharma, Basel, Switzerland.
authors: Siew Hwa
authors: SH
authors: Ong
mesh_terms: D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D008297:Male; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D049994:Sodium Potassium Chloride Symporter Inhibitors; D014665:Vasodilator Agents